| scholarly article | Q13442814 |
| P50 | author | Gareth Evans | Q29642643 |
| P2093 | author name string | Elizabeth A Jones | |
| Andrew Shenton | |||
| Mohammed Imran Sajid | |||
| P2860 | cites work | Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service | Q57266646 |
| The hedgehog pathway and basal cell carcinomas | Q95721032 | ||
| Nevoid basal cell carcinoma syndrome (Gorlin syndrome) | Q21202903 | ||
| Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident | Q24310445 | ||
| Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome | Q24336457 | ||
| Human homolog of patched, a candidate gene for the basal cell nevus syndrome | Q28281033 | ||
| The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas | Q28288407 | ||
| Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients | Q28292205 | ||
| PTCH mutations: distribution and analyses | Q28292366 | ||
| Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome | Q28307305 | ||
| Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations | Q30495361 | ||
| Complications of the naevoid basal cell carcinoma syndrome: results of a population based study | Q33595421 | ||
| Nevoid basal cell carcinoma (Gorlin) syndrome | Q35951367 | ||
| The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma | Q35993240 | ||
| The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma | Q36422767 | ||
| Predictors of the risk of mortality in neurofibromatosis 2 | Q37202827 | ||
| Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts | Q38510595 | ||
| Nevoid basal cell carcinoma syndrome: review of 118 affected individuals | Q40678901 | ||
| PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study | Q42208514 | ||
| Spectrum of PTCH1 mutations in French patients with Gorlin syndrome | Q42446262 | ||
| Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. | Q42719337 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 217378 | |
| P577 | publication date | 2010-09-28 | |
| P1433 | published in | Journal of Skin Cancer | Q26842488 |
| P1476 | title | Basal cell carcinomas in gorlin syndrome: a review of 202 patients | |
| P478 | volume | 2011 |
| Q36406904 | Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome |
| Q42511712 | Clinical and radiological features in young individuals with nevoid basal cell carcinoma syndrome |
| Q42511026 | Clinical manifestations and treatment for keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome: a study in 25 Japanese patients |
| Q35477995 | Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome |
| Q38013102 | Congenital hypotrichosis, eruptive milia, and palmoplantar pits: a case report with review of literature |
| Q53148301 | Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). |
| Q38672696 | Delayed diagnosis of Gorlin syndrome: Learning from mistakes! |
| Q64110314 | Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing |
| Q38807597 | Diagnosis and Management of Hereditary Basal Cell Skin Cancer |
| Q42459126 | Early-onset acral basal cell carcinomas in Gorlin syndrome |
| Q49548506 | Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk and prognosis. |
| Q64240239 | Global gene expression of histologically normal primary skin cells from BCNS subjects reveals "single-hit" effects that are influenced by rapamycin |
| Q41615625 | Gorlin-Goltz Syndrome: A Rare Case Report of a 11-Year-Old Child |
| Q37136993 | Hereditary nonmelanoma skin cancer |
| Q37856435 | Hereditary tumour syndromes featuring basal cell carcinomas |
| Q40175707 | Imaging findings in a case of Gorlin-Goltz syndrome: a survey using advanced modalities |
| Q41857270 | Incidental finding of lamellar calcification of the falx cerebri leading to the diagnosis of gorlin-goltz syndrome |
| Q58795605 | Infantile-onset palmo-plantar basal cell carcinomas and pits in Gorlin syndrome |
| Q42456221 | Intronic splicing mutations in PTCH1 cause Gorlin syndrome. |
| Q38194590 | Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies |
| Q42483872 | Mesenteric cysts in naevoid basal cell carcinoma syndrome: a mimic of metastatic disease. |
| Q42176413 | Multiple orthokeratinized odontogenic cysts: a case report |
| Q54764863 | Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci. |
| Q35487317 | New basal cell carcinoma susceptibility loci |
| Q35190387 | Novel patched 1 mutations in patients with nevoid basal cell carcinoma syndrome--case report |
| Q89181527 | PTCH1 isoform 1b is the major transcript in the development of basal cell nevus syndrome |
| Q37166764 | Perigestational dietary folic acid deficiency protects against medulloblastoma formation in a mouse model of nevoid basal cell carcinoma syndrome |
| Q41963939 | Radiological features of familial Gorlin-Goltz syndrome. |
| Q36923522 | Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond |
| Q55282893 | The relevance of a suppressor of fused (SUFU) mutation in the diagnosis and treatment of Gorlin syndrome. |
| Q26782853 | Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome |
| Q90266281 | Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer |
Search more.